Genome & Company Report issue

Foundation Phase 1
Founded: Seoul Korea, Republic of (2015)

Organization Overview

First Clinical Trial
2020
NCT04601402
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Genome & Company